Ikena Oncology Inc

NASDAQ:IKNA  
12.95
-0.15 (-1.14%)
Earnings Announcements

Ikena Oncology Reports Second Quarter 2021 Financial Results And Provides Update On Key Programs

Published: 08/12/2021 11:46 GMT
Ikena Oncology Inc (IKNA) - Ikena Oncology Reports Second Quarter 2021 Financial Results and Provides Update on Key Programs.
Ikena Oncology Qtrly Loss per Share 35 Cents.
Revenue is expected to be $4.05 Million
Adjusted EPS is expected to be -$0.42

Next Quarter Revenue Guidance is expected to be $5.52 Million
Next Quarter EPS Guidance is expected to be -$0.54

More details on our Analysts Page.